Editorial Commentary
Can we successfully define and target BRCA-like breast cancers?
Translational Cancer Research
2024;
13
(1)
:1-5
.
(31 January 2024)
Current concept of low-grade serous ovarian carcinoma
Translational Cancer Research
2024;
13
(1)
:6-10
.
(31 January 2024)
How far does a new horizon extend for rucaparib in metastatic prostate cancer?
Translational Cancer Research
2024;
13
(1)
:11-14
.
(31 January 2024)
CodeBreak 200: study limitations, and future directions
Translational Cancer Research
2024;
13
(1)
:15-21
.
(31 January 2024)
Immune checkpoint inhibitors in combination with chemotherapy for patients with biliary tract cancer: what did we learn from TOPAZ-1 and KEYNOTE-966
Translational Cancer Research
2024;
13
(1)
:22-24
.
(31 January 2024)
Original Article
Identification of C4BPA as biomarker associated with immune infiltration and prognosis in breast cancer
Translational Cancer Research
2024;
13
(1)
:25-45
.
(31 January 2024)
Postoperative complications and determinant of selecting non intracorporeal urinary diversion in patients undergoing robot-assisted radical cystectomy: an initial experience
Translational Cancer Research
2024;
13
(1)
:46-56
.
(31 January 2024)
Robot-assisted radical prostatectomy using the novel hinotoriTM surgical robot system: initial experience and operation learning curve at a single institution
Translational Cancer Research
2024;
13
(1)
:57-64
.
(31 January 2024)
A pancancer analysis of histone deacetylase 3 in human tumors
Translational Cancer Research
2024;
13
(1)
:65-80
.
(31 January 2024)
Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis
Translational Cancer Research
2024;
13
(1)
:81-101
.
(31 January 2024)
Proteome-wide identification and functional analysis of ubiquitinated proteins in Hepa1-6 cells by knockdown of E3 ubiquitin ligase SIAH1
Translational Cancer Research
2024;
13
(1)
:102-111
.
(31 January 2024)
Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma
Translational Cancer Research
2024;
13
(1)
:112-136
.
(31 January 2024)
The safety and efficacy of anti-PD-1 inhibitor-based combinational therapy in non-small cell lung cancer patients with oncogenic alterations
Translational Cancer Research
2024;
13
(1)
:137-149
.
(31 January 2024)
Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma
Translational Cancer Research
2024;
13
(1)
:150-172
.
(31 January 2024)
Preparation of hepatocellular carcinoma mRNA vaccines based on potential tumor targets and immunophenotypes
Translational Cancer Research
2024;
13
(1)
:173-190
.
(31 January 2024)
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro
Translational Cancer Research
2024;
13
(1)
:191-201
.
(31 January 2024)
The value of intratumoral and peritumoral radiomics features in differentiating early-stage lung invasive adenocarcinoma (≤3 cm) subtypes
Translational Cancer Research
2024;
13
(1)
:202-216
.
(31 January 2024)
Multiple databases analyzed the prognosis prediction of renin secretion pathway-related genes in renal clear cell carcinoma and immunotherapy
Translational Cancer Research
2024;
13
(1)
:217-230
.
(31 January 2024)
Comparison of the prognosis of medullary breast carcinoma and invasive ductal carcinoma: a SEER-based study
Translational Cancer Research
2024;
13
(1)
:231-248
.
(31 January 2024)
A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
Translational Cancer Research
2024;
13
(1)
:249-267
.
(31 January 2024)
The predictive value of computed tomography value on high-resolution images in differentiating invasive from indolent lung adenocarcinoma
Translational Cancer Research
2024;
13
(1)
:268-277
.
(31 January 2024)
The ultrasound-based radiomics-clinical machine learning model to predict papillary thyroid microcarcinoma in TI-RADS 3 nodules
Translational Cancer Research
2024;
13
(1)
:278-289
.
(31 January 2024)
The efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable stage II–IV non-small cell lung cancer: a preliminary study
Translational Cancer Research
2024;
13
(1)
:290-298
.
(31 January 2024)
Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics
Translational Cancer Research
2024;
13
(1)
:299-316
.
(31 January 2024)
Potential added value of computed tomography radiomics to multimodal prediction models for benign and malignant breast tumors
Translational Cancer Research
2024;
13
(1)
:317-329
.
(31 January 2024)
Comprehensive profiling of cell subsets of gastric cancer and liver metastasis based on single cell RNA-sequencing analysis
Translational Cancer Research
2024;
13
(1)
:330-347
.
(31 January 2024)
Sinensetin suppresses breast cancer cell progression via Wnt/β-catenin pathway inhibition
Translational Cancer Research
2024;
13
(1)
:348-362
.
(31 January 2024)
Spatial epidemiological analysis of the burden of liver cancer in China
Translational Cancer Research
2024;
13
(1)
:363-370
.
(31 January 2024)
Prognostic value of preoperative combined with postoperative systemic immune-inflammation index for disease-free survival after radical rectal cancer surgery: a retrospective cohort study
Translational Cancer Research
2024;
13
(1)
:371-380
.
(31 January 2024)
Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma
Translational Cancer Research
2024;
13
(1)
:381-393
.
(31 January 2024)
Developing and validating the model of tumor-infiltrating immune cell to predict survival in patients receiving radiation therapy for head and neck squamous cell carcinoma
Translational Cancer Research
2024;
13
(1)
:394-412
.
(31 January 2024)
Downregulation of homeobox B8 in attenuating non-small cell lung cancer cell migration and invasion though the epithelial-mesenchymal transition pathway
Translational Cancer Research
2024;
13
(1)
:413-422
.
(31 January 2024)
LncRNA HEIH modulates the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-193a-5p/CDK8 axis
Translational Cancer Research
2024;
13
(1)
:423-436
.
(31 January 2024)
A human serum albumin-indocyanine green complex offers improved tumor identification in fluorescence-guided surgery
Translational Cancer Research
2024;
13
(1)
:437-452
.
(31 January 2024)
Review Article
Current status of robot-assisted total pelvic exenteration focusing on the field of urology: a clinical practice review
Translational Cancer Research
2024;
13
(1)
:453-461
.
(31 January 2024)
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review
Translational Cancer Research
2024;
13
(1)
:462-470
.
(31 January 2024)
Case Report
First case report of robot-assisted radical cystectomy and intracorporeal urinary diversion using the hinotori Surgical Robot System
Translational Cancer Research
2024;
13
(1)
:471-479
.
(31 January 2024)
Erratum
Erratum to hypofractionation in prostate cancer radiotherapy
Translational Cancer Research
2024;
13
(1)
:480-483
.
(31 January 2024)
